GENETIC CONSTRUCT CODING STRUCTURE OF T-CELL CHIMERIC RECEPTOR BASED ON SINGLE-CHAIN VHH ANTIBODIES SPECIFIC TO TUMOUR RECEPTOR CD47 FOR THE TARGETED IMMUNOTHERAPY OF MALIGNANT GROWTHS Russian patent published in 2019 - IPC C12N15/86 C12N15/09 C07K19/00 A61K35/17 A61P35/00 

Abstract RU 2707535 C2

FIELD: medicine.

SUBSTANCE: invention relates to biotechnology, specifically to the production of a lentiviral vector for the expression of a chimeric antigenic receptor (CAR) based on a CD47 VHH antibody in human T-cells, and can be used in medicine.

EFFECT: obtained target T-cells presenting CAR to CD47 are characterized by high level of CAR expression, low immunogenicity and increased circulation time in the body and can be used for effective immunotherapy of malignant growths.

1 cl, 3 dwg, 3 ex

Similar patents RU2707535C2

Title Year Author Number
RECOMBINANT STRAIN OF HERPESVIRUS SAIMIRI FOR OBTAINING POPULATIONS OF IMMORTALISED AUTOLOGOUS T LYMPHOCYTES EXPRESSING PAIRED CHIMERIC RECEPTORS AGAINST CD44 AND CD133 TUMOUR ANTIGENS 2020
  • Chumakov Stepan Petrovich
  • Kravchenko Iuliia Evgenevna
  • Kravchenko Dmitrii Sergeevich
  • Frolova Elena Ivanovna
RU2771081C2
CHIMERIC ANTIGENIC RECEPTORS WITH MND-PROMOTER 2015
  • Morgan, Richard
  • Friedman, Kevin
  • Ryu, Byoung
RU2708311C2
CHIMERIC ANTIGENIC RECEPTORS WITH MND PROMOTER 2015
  • Morgan, Richard
  • Friedman, Kevin
  • Ryu, Byoung
RU2799573C2
NK CELL LINE EXPRESSING PSMA-SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND SECRETING CD47/SIRPA INTERACTION BLOCKER 2020
  • Gorchakov Andrej Aleksandrovich
  • Kulemzin Sergej Viktorovich
  • Chikaev Anton Nikolaevich
  • Taranin Aleksandr Vladimirovich
RU2757353C1
METHOD FOR PRODUCING MODEL IMMORTALIZED CELL LINE CONTAINING RECONSTRUCTED B-CELL RECEPTOR OF NON-HODGKIN LYMPHOMAS 2018
  • Stepanov Aleksej Vyacheslavovich
  • Ukrainskaya Valeriya Mikhajlovna
  • Belogurov Aleksej Anatolevich
  • Gabibov Aleksandr Gabibovich
RU2720912C1
MULTI-CHAIN CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF 2013
  • Smit Dzhulianna
  • Sharenberg Endryu
  • Manniui Sesil
  • Ekem Zhyusten
RU2663725C2
CD19-SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF 2014
  • Galetto Roman
  • Smit Dzhulianne
  • Sharenberg Endryu
  • Shiffer-Manniui Sesil
RU2727447C2
LABELED CHIMERIC EFFECTOR MOLECULES AND RECEPTORS THEREOF 2014
  • Riddell, Stanley, R.
  • Liu, Lingfeng
RU2729463C2
CD33-SPECIFIC CHIMERIC ANTIGENIC RECEPTORS FOR CANCER IMMUNOTHERAPY 2015
  • Galetto Roman
RU2701341C2
PHARMACEUTICAL COMPOSITION POSSESSING ANTITUMOUR EFFECT, AND METHOD FOR REDUCING PD-L1 INHIBITING EFFECT ON HUMAN T-CELLS 2016
  • Wu Zhao
RU2688692C2

RU 2 707 535 C2

Authors

Chumakov Stepan Petrovich

Kravchenko Yuliya Evgenevna

Kravchenko Dmitrij Sergeevich

Frolova Elena Ivanovna

Dates

2019-11-27Published

2017-12-28Filed